- Report
- November 2022
- 40 Pages
France
From €1466EUR$1,500USD£1,224GBP
- Report
- November 2022
- 40 Pages
China
From €1466EUR$1,500USD£1,224GBP
- Report
- November 2022
- 40 Pages
Brazil
From €1466EUR$1,500USD£1,224GBP
- Report
- November 2022
- 80 Pages
Africa
From €1954EUR$2,000USD£1,631GBP
- Report
- March 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- March 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- March 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Book
- April 2013
- 512 Pages
Contrast media, also known as contrast agents, are substances used to enhance the visibility of organs and tissues during medical imaging procedures. These agents are typically administered intravenously, orally, or rectally, depending on the type of imaging procedure being performed. Contrast media can be used to improve the clarity of images obtained from X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and ultrasound scans.
Contrast media are typically composed of iodine, barium, or gadolinium. Iodine-based contrast media are used to improve the visibility of organs and tissues during X-ray imaging procedures. Barium-based contrast media are used to improve the visibility of organs and tissues during CT scans and MRI scans. Gadolinium-based contrast media are used to improve the visibility of organs and tissues during MRI scans.
Some of the major companies in the contrast media market include Bayer AG, Bracco Imaging S.p.A., Guerbet Group, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, and Medtronic plc. Show Less Read more